Effect of Body Weight Loading on Urinary Electrolyte Excretion
EBU
1 other identifier
interventional
15
1 country
1
Brief Summary
Title: Effect of body weight loading on urinary electrolyte excretion Swedish Title: Effekt av belastning på utsöndring av elektrolyter Study period: Q2-Q3 2017 Study site: The study will be performed at the Institution for Neurology and Physiology, Sahlgrenska Academy, University of Gothenburg. Principal Investigator is John-Olov Jansson, MD, PhD, Professor at Institute of Neuroscience and Physiology, University of Gothenburg Background and study design: Weight reduction can be obtained by decreased appetite or increased metabolism. However, acute weight loss can also be obtained by loss of fluids - for example by increased urinary loss of fluid and salts, so called elctrolytes. Preliminary results from a laboratory lesson for the Master of Science in Medicine program at University of Gothenburg suggest that carrying a 10 kg weight vest could increase urinary excretion of Na+, K+ and Cl-. The purpose of this study is to investigate this further in a more controlled research setting. If confirmed, the results could potentially contribute to the development of potent diuretics or obesity medicines. The study will include 15 healthy volunteers and consist of three study days with about one week between each study day. The study subjects will go through a different study procedure each study day, and a randomized cross-over study design will be used to determine which procedure each day. Procedure 1: Wearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is that it has been considered that the effect may be transmitted by weight loading of the lower extremities. Procedure 2: Wearing a weight vest with 1 % of body weight standing for seven hours, as a control for procedure 1, with lower loading. The study subject is allowed to sit for 10 minutes each hour. Procedure 3: Wearing a weight vest with 1 % of body weight sitting for seven hours. This is a procedure with even less loading of the lower extremities than during procedure 2. Urine- and blood samples, as well as heart rate and blood pressure measurements, will be collected during the study days and analyzed in order to address the primary and secondary objectives of the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable obesity
Started Jun 2017
Shorter than P25 for not_applicable obesity
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2017
CompletedFirst Submitted
Initial submission to the registry
July 4, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 4, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 4, 2017
CompletedFirst Posted
Study publicly available on registry
July 11, 2017
CompletedApril 2, 2025
April 1, 2025
21 days
July 4, 2017
April 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sodium concentration
In urine
7 hours from start
Secondary Outcomes (17)
Urine Volume
7 hours from start
Potassium concentration
7 hours from start
Chloride concentration
7 hours from start
Calcium concentration
7 hours from start
Creatinine
7 hours from start
- +12 more secondary outcomes
Study Arms (3)
Procedure 1
EXPERIMENTALWearing a weight vest with 10 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour. The reason for this is because it has been considered that the effect may be transmitted by weight loading of the lower extremities.
Procedure 2
ACTIVE COMPARATORWearing a weight vest with 1 % of body weight standing for seven hours. The study subject is allowed to sit for 10 minutes each hour.
Procedure 3
ACTIVE COMPARATORWearing a weight vest with 1 % of body weight sitting for seven hours. This is a control group without loading of the lower extremities. This is also the normal working position for many sedentary jobs (e.g. office workers) and why this is of special interest for further investigation. There is a large body of investigative literature showing the negative health consequences of the sitting working position.
Interventions
A weight west with a weight of 10 % compared to the study subject
Study subjects will be standing for at least 50 minutes every hour
Study subjects will drink 5 ml per kg body weight at the start of experiment and continue drinking the same volume as excreted by the kidneys during the experiment
A weight west with a weight of 1 % compared to the study subject
Eligibility Criteria
You may qualify if:
- Healthy volunteers
- Signed informed consent
- Willingness to comply with study restrictions of not using alcohol, coffee etc during the hours specified below prior to each study day
You may not qualify if:
- Subjects must not enter the study if any of the following are present:
- Chronic disease requiring continuous medication or harden the participation in the study as judged by the investigator
- High blood pressure (\>140/90 mm Hg)
- Chronic pain such as pain that is constant and impairs quality of life
- Consumption of medications during the last 7 days prior the study day, not including contraceptives
- Consumption of nature medicine or supplements that results in a increased intake of a specific compound that isn't a nutrient during the last 7 days prior the study day
- Smoking, snuff use or intake of drugs during the last 7 days prior the study day
- Intake of alcohol during the last 24 hours prior the study day
- Intake of coffee and tea during the last 12 hours prior the study day
- Strenuous physical activity before the study during the last 6 hours prior the study day
- Pregnancy: Females of childbearing potential must confirm to use reliable contraception and not suspect to be pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Göteborg Universitylead
- Sahlgrenska University Hospitalcollaborator
Study Sites (1)
University of Gothenburg
Gothenburg, Box 100, S-405 30, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
John-Olov Jansson
Univeristy of Gothenburg
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- We will recruit healthy individuals who work at or close to the Institution of Neuroscience and Physiology at the Sahlgrenska Academy. We will ask healthy people who do not know the hypothesis of the study. Each study subject will be given a randomized code to use for the study. Only the study subject and the investigator will be able to connect each study subject with their randomized code. This will only be used under special circumstances, for example, if a study subject requests removal of his or her study data. As this study uses a cross-over design each subject will then be its own matched control. Subject eligibility will be established before enrolment and randomization. Subjects will be randomized strictly sequentially, as subjects are eligible for randomization. If a subject discontinues from the study, the subject number will not be reused, and the subject will not be allowed to re-enter the study.
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2017
First Posted
July 11, 2017
Study Start
June 13, 2017
Primary Completion
July 4, 2017
Study Completion
July 4, 2017
Last Updated
April 2, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share